Living Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or Region

Centre Hospitalier Universitaire Dijon157 enrolled

Overview

The development of new diagnostic tools and targeted therapy have significantly improved the management of non-Hodgkin's malignant lymphomas and thus their long-term prognosis. However, in the study of improved patient management, survival is not the only measurable indicator and preservation of quality of life is an essential component. In addition, there is little existing data regarding the determinants of quality of life in patients with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) in the general population in France.

Study Type

OBSERVATIONAL

Enrollment

157

Conditions

Diffuse Large Cell Diffuse Lymphoma Follicular Lymphoma

Interventions

QuestionnairesOTHER

QLQ-C30, SF-12, HADS, SARASON, EPICES, socio-professional data

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with DLBCL or FL between January 1, 2010 and December 31, 2017, * Alive as of January 1, 2021, * Updated patient address. Exclusion Criteria: * Other forms of Hematologic Malignancies at diagnosis, * Minors. * Person subject to legal protection (curatorship, guardianship) * Person subject to a judicial safeguard measure * Pregnant, parturient or breastfeeding woman * Adults incapable of giving consent

Outcomes

Primary Outcomes

Generic Questionnaire SF-12

Time frame: At inclusion

Specific questionnaire QLQ-C30